Liminatus Pharma, Inc. (LIMNW) stock

LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.04+0.00 (0.00%)

Close on Oct 30, 2026Market cap $189.39MP/E –Yield –

Liminatus Pharma statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Oct 30, 2026

Valuation ratiosIndustry

Market Cap: $189.39M; $265.71M
Enterprise Value: $187.82M; $146.54M
PB Ratio: 630.02; 2.13
P/TBV Ratio: 630.02; 2.47

Share statisticsIndustry

Shares Outstanding: 67M; 58M
Shares Change (YoY): 82.7%; 10.8%
Shares Change (QoQ): 24.7%; 0.54%
Float: 41M; 49M
Shares Held by Insiders: 38.7%; 11.4%
Shares Held by Institutions: 2.34%; 56.1%

Short sellingIndustry

Short Interest: 44,566; –
Short Interest Change: -24.2%; 0.60%
Days to Cover: 1.82; 4.58

Stock price statisticsIndustry

52-Week High: $141.50; –
52-Week Low: $2.75; –
20-Day Moving Average: $3.28; –
50-Day Moving Average: $3.66; –
200-Day Moving Average: $11.10; –
Average True Range (14): $0.30; –
Price Change (1 Week): -4.08%; 1.30%
Price Change (1 Month): -24.8%; -7.60%
Price Change (3 Months): -50.4%; -14.4%
Price Change (6 Months): -72.5%; -19.7%
Price Change (YTD): -90.8%; -19.6%
Price Change (1 Year): -96.0%; -21.9%
Price Change (3 Years): -99.5%; -22.6%
Price Change (5 Years): -99.4%; -75.5%
Average Volume (10 Days): 30,506; –
Average Volume (20 Days): 25,488; –
Average Volume (90 Days): 486,515; –
Relative Volume: 0.03; 0.73
Relative Strength Index (14): 34.4; 44.2
Volatility (1 Year): 177.7%; 79.5%
Beta (5 Years): 0.72; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -471.5%; -40.9%
Return on Capital Employed (ROCE): -1119.0%; -38.6%

Financial positionIndustry

Current Ratio: 1.12; 3.30
Quick Ratio: 0.99; 2.39
Debt / Equity: 4.80; 0.50
Interest Coverage: -53.78; -6.26

EfficiencyIndustry

Profits Per Employee: -$12.52M; -$705.27K
Employee Count: 1; 75
WACC: 8.56%; 10.1%

Income statement (TTM)Industry

Operating Income: -$4.07M; -$21.42M
Net Income: -$12.52M; -$22.46M
EBITDA: -$4.07M; -$16.82M
EPS (Diluted): -$0.43; -$0.83

Balance sheetIndustry

Cash & Short-Term Investments: $3.02M; $61.68M
Total Debt: $1.44M; $120.13M
Net Cash (Debt): $1.57M; $15.31M
Net Cash Per Share: $0.02; $0.66
Equity (Book Value): $300.61K; $48.79M
Book Value Per Share: $0.00; $1.36
Tangible Book Value: $300.61K; $23.91M
Working Capital: $352.04K; $74.41M

Cash flow (TTM)Industry

Operating Cash Flow: -$3.97M; -$12.24M

Dividends and yieldsIndustry

Earnings Yield: -6.61%; -20.7%

Taxes and interestIndustry

Interest Expense: $75.59K; $3.07M

Scores and fair valueIndustry

Altman Z-Score: 15.77; 0.25
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

Period	LIMNW	S&P 500	Difference	LIMNW per year	S&P 500 per year
1 month	-27.9%	-0.9%	−27.0 pts
3 months	-2.7%	+2.1%	−4.8 pts
Year to date	+14.3%	+11.7%	+2.6 pts
1 year	-68.8%	+12.4%	−81.1 pts
3 years	+59.4%	+88.6%	−29.2 pts	+16.8%	+23.5%
5 years	-95.9%	+75.9%	−171.8 pts	-47.1%	+12.0%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

0M LIMNW shares were sold short on Oct 15, 2026, up 0.0% from the previous report. At recent volumes it would take 15.0 days to buy them back. Over the last 20 sessions, 58.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 15, 2026	6,614	0.0%	441	15.0
Sep 30, 2026	6,614	0.0%	148	44.7
Sep 15, 2026	6,614	0.0%	58	114.0
Aug 31, 2026	6,614	+92.9%	3,076	2.1
Aug 14, 2026	3,429	-12.1%	1,026	3.3
Jul 31, 2026	3,901	+11.1%	2,319	1.7
Jul 15, 2026	3,511	-7.0%	3,302	1.1
Jun 30, 2026	3,775	+126.5%	5,164	1.0
Jun 15, 2026	1,667	-16.1%	2,507	1.0
May 29, 2026	1,988	-15.3%	12,822	1.0
May 15, 2026	2,347	+873.9%	3,692	1.0
Apr 30, 2026	241	+52.5%	5,318	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.